PPT-Using Policy Advocacy to Remove Barriers to Comprehensive HIV Prevention

Objectives for Module 4 Our Missions Today Review a Brief history of HIVAIDS policy advocacy Understand basic tactics for policy advocacy and how it differs from other kinds of advocacy. Presentation. LTC 328. Overview. . INTRODUCTION. . TYPE OF ABUSE AND CATEGORY. . STATISTICS OF EACH TYPE OF ABUSE. . ADVOCACY SERVICES. . DOES EVERYONE HAVE THE SIMILAR ENTITLEMENT TO THESE SERVICES . A Winnable Battle. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. Community Connections: Aligning Domestic Violence and Homeless Services . 10/25/17. Outline. What is advocacy?. What do we mean by client/survivor driven?. How does it work?. What do you see as the barriers?. Community Connections: Aligning Domestic Violence and Homeless Services . 10/25/17. Outline. What is advocacy?. What do we mean by client/survivor driven?. How does it work?. What do you see as the barriers?. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. . Appropriate Use of Public . Funds. Sabrina . Freewynn. January 22 and 23, 2015. Housekeeping . Please mute your phone. Questions. Slides will be available on HPCDP Connection. Objectives. At the end of this webinar, you will be able to:. Division of HIV/AIDS Prevention. Centers for Disease Control and Prevention. Burden of HIV in the United States. . . 1.2 M . ~. 50K. 1.2 million people . living with HIV. Approximately . 50,000 new infections annually. . HCV . testing and treatment. Lorenzo McFarland, DHA, MPH, MSW, PMP. USAF/Ret E-7 - Senior Program Manager. HIV, Hepatitis, and Related Conditions Program. Office of Specialty Care Services. Deputy Under Secretary for Health for Policy and Planning. Presenter:. INTRODUCTION. This project was supported through Federal funds from the Division of AIDS (DAIDS), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services Grant # UM01 AI068614: “Leadership Group for a Global HIV Vaccine Clinical Trials (Office of HIV/AIDS Network . Today’s Agenda . 3. Introduction of chapter leadership. What is advocacy?. How does organized medicine impact advocacy?. How do I get involved in advocacy?. 4. Meet your . AMA Leadership. at . <School> . HIV1 and slower to progress to AIDS.. Most cases are due to type1.. Modes of transmission. 1-sexual.. 2- perinatal.. 3-parenteral(occupational and intravenous drug injection).. 4- blood transfusion.. 2018. Objectives . To describe the current situation regarding new HIV infections globally. To list the global HIV prevention targets. To list all types of HIV prevention strategies and know their relative effectiveness. Geneva 2019. Dr Venkatraman Chandra-Mouli. DEFINITIONS . Human immunodeficiency virus (HIV): . A virus that targets the immune system & weakens the body’s defense system against infections. . Antiretroviral medicines (ARVs): . Rebecca Meyer, . M.s.. , M.S.W.. Why is this Important?. 2. 3. What is Advocacy?. “The act or process of supporting a cause”. Advocacy in ASD literature is any action. taken on behalf of a child with ASD to .